Endolift + PRF for Facial Rejuvenation

Endolift and injectable platelet-rich fibrin (i-PRF) target facial rejuvenation through different but potentially complementary pathways. Endolift delivers controlled subdermal laser energy to promote tissue contraction and collagen remodeling, while i-PRF supplies an autologous fibrin matrix rich in platelets, leukocytes and growth factors. A 2026 case report used i-PRF one day before, one week after and one month after a single Endolift session and reported visible short-term improvement in skin tightness, texture and overall appearance. The evidence is promising but limited to one patient and four weeks of follow-up.

Endolift + i-PRF Facial Rejuvenation in Abu Dhabi

Facial aging is rarely a single-layer problem. Skin laxity, loss of elasticity, fine lines and changes in tissue quality can occur together. A combined strategy is therefore designed around two goals: structural tightening and biological regeneration. Endolift targets the deeper tissue through a micro-optical fiber, while injectable platelet-rich fibrin (i-PRF) provides an autologous regenerative matrix rich in platelets, leukocytes and growth factors.

A 2026 case report described a 56-year-old woman treated with a deliberately timed i-PRF schedule around one Endolift session. The protocol used i-PRF on Day −1, Endolift on Day 0, then additional i-PRF at Day +7 and Day +30. At the four-week follow-up, clinical examination and standardized photographs showed improvement in skin tightness, texture and overall facial appearance, with high patient satisfaction and only mild, transient adverse effects.

EVIDENCE FIRST :

This is early evidence, not a standardized universal protocol. The publication is a single-patient case report with only four weeks of final follow-up, so the combined approach should be presented as promising rather than proven superior to Endolift alone.

What Is Endolift?

Endolift is a minimally invasive laser procedure that delivers energy into the subdermal tissue through a fine optical fiber. In the source paper, the authors describe immediate tissue contraction together with longer-term collagen remodeling. The treatment is used to address skin laxity, facial contour and tissue quality without a surgical incision.

• Subdermal energy delivery through a micro-optical fiber.
• Immediate tissue contraction from a controlled thermal effect.
• A biological remodeling response that continues after treatment.
• Potential improvement in laxity, texture and facial contour in appropriately selected patients.

What Is i-PRF — and Is It the Same as PRP?

The study did not use conventional PRP. It used injectable platelet-rich fibrin (i-PRF). In the reported protocol, venous blood was collected in tubes without anticoagulants and centrifuged to isolate a liquid fibrin matrix rich in platelets, leukocytes and growth factors. Because many patients search for “PRP facial rejuvenation,” that phrase can be included naturally for search visibility, but the scientific evidence on this page should be labeled correctly as i-PRF.

Why Combine Endolift With i-PRF?

The rationale in the case report is a combination of thermal and biological stimulation. Endolift creates a controlled local thermal stimulus in the superficial dermal/subdermal tissue, initiating tissue contraction and collagen remodeling. i-PRF is then used as a biological support intended to enhance the regenerative environment through autologous platelets, leukocytes and growth factors.

1. Prime the tissue: i-PRF was injected one day before Endolift in the reported schedule.
2. Create the structural stimulus: Endolift was performed on Day 0 to initiate tightening and collagen remodeling.
3. Support early recovery: a second i-PRF treatment was administered one week after the laser.
4. Sustain the regenerative phase: a third i-PRF treatment was administered one month after Endolift.

The Treatment Timeline at a Glance

Timing	Treatment	Purpose in the Report	Evidence Status
Day −1	i-PRF injection	Biological “priming” before laser treatment	Proposed mechanism; not yet validated in comparative trials
Day 0	Single Endolift session	Controlled thermal stimulus, tissue contraction and collagen remodeling	Established Endolift mechanism; combination evidence is early
Day +7	i-PRF injection	Support early healing and regenerative signaling	Case-report protocol
Day +30	i-PRF injection	Support ongoing collagen synthesis	Case-report protocol

What Did the Published Case Actually Show?

The patient was 56 years old and presented with facial laxity, reduced elasticity and fine lines. At four weeks after completing the scheduled treatment, the authors reported visible improvement in skin texture, elasticity and tightness, particularly in the lower face and neck. The patient rated the result as “very satisfied” on a four-point satisfaction scale. An independent dermatologist also reported marked improvement in skin quality and tightness.

Reported Outcome	What the Case Report Found
Skin tightness	Marked short-term improvement on clinical assessment and photography
Texture / elasticity	Visible and clinically reported improvement within four weeks
Overall facial appearance	More youthful appearance reported by the authors
Patient satisfaction	“Very satisfied” — score 4/4
Adverse effects	Mild pain, redness and swelling; resolved within a few days
Delayed / severe events	None reported during the four-week follow-up

How the Two Treatments May Complement Each Other

Component	Primary Role	Tissue-Level Goal	Patient-Facing Interpretation
Endolift	Controlled laser energy	Tissue contraction + collagen remodeling	Address laxity and contour from a deeper level
i-PRF	Autologous regenerative concentrate	Biological support with platelets, leukocytes and growth factors	Support the healing / regenerative environment
Combination	Thermal + biological stimulation	Potentially complementary remodeling	Aim to improve firmness, texture and overall skin quality together

The authors describe i-PRF as a “biological catalyst” within the combined protocol. This is a mechanistic interpretation from a case report, not proof that i-PRF increases the effect size of Endolift. A randomized or controlled comparison would be required to demonstrate true synergy.

What Areas Can Be Considered?

The published case focused on facial rejuvenation with visible changes particularly in the neck and lower face. In clinical practice, the treatment plan should be based on the patient’s actual concern and anatomy rather than automatically treating the whole face.

• Lower-face laxity and early contour softening.
• Neck skin quality and laxity when appropriate for Endolift.
• Fine lines and textural aging as part of a broader rejuvenation plan.
• Patients seeking a regenerative, minimally invasive strategy rather than surgical lifting.

PATIENT SELECTION

This combined approach is not a replacement for surgery in patients with advanced skin excess, nor does the source study establish that it can correct every cause of facial aging. Bone structure, fat loss, muscle activity, pigmentation and severe laxity may require different or additional treatments.

Who May Be a Good Candidate?

• Adults with mild-to-moderate facial or neck laxity seeking a minimally invasive option.
• Patients interested in collagen-focused rejuvenation rather than only volume replacement.
• Patients who accept that collagen remodeling is gradual and that the published combination evidence is still early.
• Patients able to follow post-treatment care and return for planned regenerative sessions if clinically appropriate.
• Patients without contraindications identified during medical assessment.

Who May Need a Different Plan?

• Patients with advanced tissue descent or major excess skin who are better suited to surgical assessment.
• Patients whose main concern is volume loss rather than laxity or texture.
• Patients with active skin infection or other medical factors that make elective treatment inappropriate.
• Patients expecting guaranteed or immediate “facelift-equivalent” results from a minimally invasive procedure.

Recovery, Side Effects and Safety

In the reported case, adverse effects were mild and short-lived. The patient experienced pain, redness and swelling immediately after treatment, and these resolved within a few days without medical intervention. No delayed or severe adverse events were reported during the four-week follow-up.

What Was Reported	Course	How to Communicate It
Mild pain	Transient	Possible short-term discomfort
Redness	Resolved within days	Expected inflammatory response may occur
Swelling	Resolved within days	Short-term swelling is possible
Severe / delayed complications	Not observed in this single case	Cannot be interpreted as zero risk in larger populations

When Should Results Be Judged?

The case report documented visible changes by four weeks, but the authors explicitly state that four weeks is too short to evaluate the full process of collagen remodeling and neocollagenesis. They note that these biological processes typically unfold over approximately 3–6 months. Therefore, early tightening and texture changes should not be confused with the final long-term result.

• Early phase: swelling settles and initial tissue changes become visible.
• Weeks to months: collagen remodeling may continue to evolve.
• Long-term durability: not established by this case report; longer follow-up is needed.

Endolift + i-PRF vs Endolift Alone

Question	Endolift Alone	Endolift + i-PRF
Main concept	Laser-based tissue tightening / remodeling	Laser remodeling + autologous regenerative support
Evidence base	Supported across multiple Endolift studies for several indications	Combination evidence in this paper is a single case report
Number of visits	Often centered around one Endolift session, depending on indication	Published schedule used one Endolift + three i-PRF visits
Proven superiority?	—	No. The study did not compare the combination against Endolift alone
Best use of evidence	Established procedure-specific literature	Promising individualized multimodal strategy

---